Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: Alpha Lipoic Acid in Geographic Atrophy [Phase 1, Phase 2]

View source ↗

Summary

Trial update for alpha lipoic acid in geographic atrophy as part of age-related macular degeneration; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of Pennsylvania | Conditions: Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-06